BA
UTHR icon

Boston Advisors’s United Therapeutics UTHR Stock Holding History

Boston Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,817
Closed -$1.45M – 671
2017
Q4 		$1.45M Sell
9,817
-580
-6% -$73.7K 0.03% 311
2017
Q3 		$1.22M Buy
10,397
+60
+0.6% +$7.66K 0.03% 336
2017
Q2 		$1.34M Sell
10,337
-413
-4% -$51.5K 0.03% 340
2017
Q1 		$1.46M Sell
10,750
-2,990
-22% -$453K 0.03% 311
2016
Q4 		$1.97M Buy
13,740
+4,395
+47% +$561K 0.05% 294
2016
Q3 		$1.1M Buy
9,345
+5,650
+153% +$679K 0.03% 343
2016
Q2 		$391K Sell
3,695
-1,210
-25% -$135K 0.01% 538
2016
Q1 		$547K Sell
4,905
-6,135
-56% -$776K 0.01% 433
2015
Q4 		$1.73M Sell
11,040
-1,475
-12% -$215K 0.04% 276
2015
Q3 		$1.64M Sell
12,515
-2,895
-19% -$464K 0.06% 308
2015
Q2 		$2.68M Sell
15,410
-1,810
-11% -$326K 0.11% 185
2015
Q1 		$2.97M Buy
17,220
+1,235
+8% +$188K 0.12% 189
2014
Q4 		$2.07M Buy
15,985
+6,120
+62% +$789K 0.09% 198
2014
Q3 		$1.27M Sell
9,865
-10,955
-53% -$1.13M 0.05% 252
2014
Q2 		$1.84M Buy
20,820
+260
+1% +$25K 0.08% 220
2014
Q1 		$1.93M Sell
20,560
-235
-1% -$24K 0.09% 213
2013
Q4 		$2.35M Sell
20,795
-4,030
-16% -$363K 0.11% 173
2013
Q3 		$1.96M Buy
24,825
+11,805
+91% +$863K 0.1% 182
2013
Q2 		$857K Buy
+13,020
New +$839K 0.04% 261

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Boston Advisors's UTHR Position: Q1 2018 in Review

Boston Advisors sold out of United Therapeutics (UTHR) in Q1 2018, closing a stake of 9,817 shares — an estimated $1.45M sold.

Boston Advisors first reported a position in UTHR in Q2 2013 and held it in 19 quarters. The position peaked at $2.97M in Q1 2015. 374 funds tracked by Wall St. Rank hold UTHR as of Q1 2018.

  • Boston Advisors reported no remaining United Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Boston Advisors sold 9,817 United Therapeutics shares in Q1 2018, an estimated $1.45M.
  • Boston Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 19 quarters.
  • Boston Advisors's United Therapeutics position peaked at $2.97M in Q1 2015.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2018.

Based on Boston Advisors's 13F filing for Q1 2018, filed 25 Apr 2018.